Hoth Therapeutics, Inc.
Support and Resistance Levels
Past performance
News About HOTH
All events for HOTH
All deals for HOTH
Financial Ratios
Financial Statements
HOTH vs Sector & Peers
About Hoth Therapeutics, Inc.
Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY. Website hoththerapeutics.com
Headquarters Hoboken, NY, US